AKEBIA THERAPEUTICS, INC. Severance Costs
AKEBIA THERAPEUTICS, INC. (AKBA) reported Severance Costs of $11.40 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2022-11-03
- AKEBIA THERAPEUTICS, INC. severance costs for the quarter ending 2022-09-30 was $11.40M.
- AKEBIA THERAPEUTICS, INC. severance costs for the quarter ending 2022-06-30 was $11.20M.
- AKEBIA THERAPEUTICS, INC. severance costs for the quarter ending 2015-09-30 was $73.00K.
- AKEBIA THERAPEUTICS, INC. severance costs for the quarter ending 2015-06-30 was $100.00K.
- AKEBIA THERAPEUTICS, INC. severance costs for fiscal 2014 was $118.85K.
| Period end | Severance Costs 3 month | Severance Costs 3 month as first filed | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $11.40M 10-Q · filed 2022-11-03 | $22.60M derived: sum of 2 quarters · filed 2022-11-03 | $11.40M 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $11.20M 10-Q · filed 2022-08-04 | $11.20M 10-Q · filed 2022-08-04 | |||
| 2015-09-30 | $73.00K 10-Q · filed 2015-11-09 | $173.00K derived: sum of 2 quarters · filed 2015-11-09 | $245.00K derived: sum of 3 quarters · filed 2015-11-09 | ||
| 2015-06-30 | $100.00K 10-Q · filed 2015-08-11 | $172.00K derived: sum of 2 quarters · filed 2015-08-11 | |||
| 2015-03-31 | $72.00K 10-Q · filed 2015-05-11 | ||||
| 2014-12-31 | $118.85K 10-K · filed 2015-03-04 | ||||
| 2014-03-31 | $300.00K 10-Q · filed 2015-08-11 | $323.69K 10-Q · filed 2014-05-12 | |||
| 2013-09-30 | $46.68K 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |